Scarica l'app Stockscreener
2.17
3.83%
0.08
Dopo l'orario di chiusura:
2.14
-0.03
-1.38%
Precedente Chiudi:
$2.09
Aprire:
$2.13
Volume 24 ore:
3.45M
Relative Volume:
0.21
Capitalizzazione di mercato:
$271.16M
Reddito:
-
Utile/perdita netta:
$-112.46M
Rapporto P/E:
-1.3232
EPS:
-1.64
Flusso di cassa netto:
$-99.89M
1 W Prestazione:
-8.82%
1M Prestazione:
+582.18%
6M Prestazione:
+48.12%
1 anno Prestazione:
+129.68%
Intervallo 1D:
$2.12
$2.27
Intervallo di 1 settimana:
$1.97
$2.49
Portata 52W:
$0.1311
$3.29
Vor Biopharma Inc Stock (VOR) Company Profile
Nome
Vor Biopharma Inc
Settore
Industria
Telefono
617-655-6580
Indirizzo
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Confronta VOR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
2.17 | 261.17M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Iniziato | Wedbush | Outperform |
| 2022-04-27 | Iniziato | Goldman | Neutral |
| 2021-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-02 | Iniziato | Oppenheimer | Outperform |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-03-03 | Iniziato | Evercore ISI | Outperform |
| 2021-03-02 | Iniziato | Goldman | Sell |
| 2021-03-02 | Iniziato | Stifel | Buy |
Mostra tutto
Vor Biopharma Inc Borsa (VOR) Ultime notizie
What drives Vor Biopharma Inc. stock priceExtraordinary performance - Autocar Professional
Is Vor Biopharma Inc. a good long term investmentSuperior stock growth - PrintWeekIndia
What analysts say about Vor Biopharma Inc. stockHigh-yield growth strategies - Autocar Professional
Vor Biopharma Inc. Stock Analysis and ForecastJaw-dropping returns - Autocar Professional
Vor Biopharma Inc.'s (NASDAQ:VOR) top holders are insiders and they are likely disappointed by the recent 14% drop - Yahoo Finance
H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, Sets a $3 Price Target - MSN
Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors - Stock Titan
Vor Biopharma's Strategic Turnaround and the Case for Immediate Investment - AInvest
Vor Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - AInvest
10 Hot Penny Stocks to Invest in Now - Insider Monkey
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vor Bio Awards Massive 5.3M Share Package to New Development Chief: Full Grant Details Revealed - Stock Titan
Vor Biopharma shares rise 2.52% premarket after appointing Qing Zuraw as Chief Development Officer. - AInvest
Why Vor Biopharma Inc. stock is on top investor watchlistsFree Real-Time Market Predictions - Newser
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer - Yahoo Finance
Vor Biopharma Faces Crucial Market Shifts Amid Latest Developments - StocksToTrade
Vor Biopharma Stock Faces Volatile Week Amid Mixed Financial Reports - timothysykes.com
Vor Biopharma Inc. shares rise 2.00% premarket after Bonesupport CEO predicts strong growth. - AInvest
How Vor Biopharma Inc. stock performs during market volatilitySafe Entry High Exit Alerts - Newser
What makes Vor Biopharma Inc. stock price move sharplySteady Profit Stock Forecasts - Newser
Why Vor Biopharma Inc. stock attracts strong analyst attentionBreakout Confirmation Tool - newser.com
Vor Biopharma Stock’s Rollercoaster: Time to Buy? - StocksToTrade
VOR’s 2025 Market Dance: Up 174.66% – Time to Invest? - investchronicle.com
Vor Biopharma Explodes 22% – What’s Fueling the Surge? - AInvest
Vor Biopharma Inc Azioni (VOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):